Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...
Nottinghamshire Live on MSN
'Mum, I don't feel safe here', read Sophie's text. Four weeks later she died
“Mum, I don’t feel safe here,” reads a message to her mother, Leisa, from that short time. At the end of Sophie’s three-week ...
Pancreatic cancer, a notorious 'silent killer,' may now reveal early warnings in the legs. Doctors are highlighting leg pain, ...
Experts share advice for junior colleagues before their first case, including basic keys to success and pitfall avoidance, what to watch for when observing a case, and questions to ask and when to ask ...
Using real world data, researchers sought to compare outcomes in patients living in urban and non-urban communities who were treated for pulmonary embolism.
Dear Dr. Roach: I am struggling with a decision process due to a lack of consensus among various physicians. I was fortunate ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) ...
A new study investigating neuroinflammation in the ventral tegmental area (VTA) of the brain, a small, midbrain dopaminergic ...
A new discovery from the lab of YouYang Zhao, Ph.D., from Stanley Manne Children's Research Institute at Ann & Robert H.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback